Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs GNRC✓SelectedUSD · GNRCGSK vs GNRC performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs GNRC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.9%
GNRC return
+81.1%
Excess return
-28.1%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGNRCExcessAlpha
1D-1.6%-0.2%-1.4%-1.6%
7D-4.7%+6.3%-11.0%-4.7%
30D-4.7%+5.4%-10.1%-4.8%
3M-8.8%-2.7%-6.0%-8.8%
6M-4.6%-15.9%+11.3%-4.7%
YTD+1.0%+50.4%-49.4%-2.1%
1Y+6.9%+39.3%-32.4%+4.0%
All+52.9%+81.1%-28.1%+41.6%

Cumulative growth

Daily Returns

Daily percentage return beside GNRC.

Daily Out/Under-Performance

Portfolio return minus GNRC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GNRC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GNRC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling